Clinical Trial Update: Modulation of Immune Activation by Aspirin [Phase 2]

View source ↗

Summary

Phase 2 clinical trial examining aspirin's ability to modulate immune activation in HIV-1 infection; results for the completed study were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | Conditions: HIV-1 Infection | Phase 2 | Status: COMPLETED | Results posted: 2016-07-07